Home
Longevity
Diseases of Aging
Status Quo
Stem Cells Solutions
Technologies (ASC, PRC, PPC, pMSC)
Therapeutic focus
Liver
Heart
Arteries
About
Our Mission
Team Management
Patents
Careers
News
Industry News
Bio News Letter
News
Hot Science
Contact
Technologies
Overview
Platforms
STEM CELL REVIVIFY™
Pipeline
About Us
Our Mission
Management Team
Patents
Collaboration Opportunities
Careers
Contact Us
News and Resources
Industry News
Bio News Letter
News and Resources
Science
Contact Us
News and Resources
March 26, 2024
Surprising longevity boosters: top medications revealed
Read more
March 12, 2024
Patent spotlight: zip11 gene and the future of anti-aging therapies
Read more
February 27, 2024
Harvard's youth protein: turning back the aging clock
Read more
January 23, 2024
Immorta Bio Welcomes Dr. Vlad Bykoriz as its Chief Medical Officer
Read more
January 2, 2024
Immorta Bio Announces Personalized Progenitor Cell Platform for Organ Specific Regeneration
Read more
December 18, 2023
Immorta Bio Files Patent on Reversing Cellular Aging by Creation of Personalized Regenerative Cells
Read more
December 6, 2023
Venvalo Group Launches Immorta Bio, Inc Aimed at Providing Unlimited Personalized Cells for Treating Diseases of Aging and Treating Aging as Disease™
Read more
Previous
Subscribe to Immorta Bio Newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Join our newsletter to stay up to date on features and releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By subscribing, you are acknowledging your consent to receive Immorta Bio newsletters
19505 Biscayne Blvd, Ste 2350 Aventura, Florida 33180
305 632-2939
info@immortabio.com
Technologies
Social Media
Pipeline
About Us
News
Investors
Copyright © Immorta Bio, Inc | All Rights Reserved
Privacy Policy
